Skip to content

Expiratory flow accelerator device versus positive expiratory pressure for tracheobronchial airway clearance after lung cancer lobectomy : a randomized non inferiority study

Expiratory flow accelerator device versus positive expiratory pressure for tracheobronchial airway clearance after lung cancer lobectomy . A randomized non inferiority study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17013255
Enrollment
Unknown
Registered
2017-11-06
Start date
2012-01-02
Completion date
Unknown
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

EFA group:Expiratory flow aceleration EFA
PEP:Positive expiratory pressure PEP

Sponsors

ASST Settelaghi Lombardia
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 81 patients aged = 18 years candidate for elective pulmonary lobectomy by thoracotomy for lung cancer were screened. Inclusion criteria were: age from 18 to 80 years, elective pulmonary lobectomy by open thoracotomy, ineffective cough postoperatively (peak flow meter 5 as rated on a visual analogue scale (VAS) on postoperative day 1

Exclusion criteria

Exclusion criteria: Exclusion criteria were: peak cough expiratory flow (PCEF) = 180 l/min or pain VAS 24 h, non collaborative patients, and patients who did not give informed consent. Patients with an effective cough, defined as PCEF =180 l/min, or pain intensity at coughing VAS < 5, were excluded from the study because the need for a support device for tracheo-bronchial mucus clearance was, according to our routine practice, not considered indicated.

Design outcomes

Primary

MeasureTime frame
Post operative pulmonary complications;

Countries

Italy

Contacts

Public ContactD'Andria Michele

Center for Thoracic Surgery, University of Insubria, Ospedale di Circolo

chiccanene@libero.it+39 3 32217901

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 4, 2026